WallStreetZenWallStreetZen

NASDAQ: INTS
Intensity Therapeutics Inc Stock Ownership - Who owns Intensity Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Intensity Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INTS insiders and whales buy or sell their stock.

INTS Shareholders

What type of owners hold Intensity Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Lewis H. Bender14.59%2,000,000$8.16MInsider
John M. Wesolowski0.04%5,000$20.40kInsider

1 of 1

INTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INTS0.00%14.63%
AVRO46.76%53.24%Net SellingNet Selling
MLEC0.04%9.18%
HCWB2.82%47.89%Net BuyingNet Buying
EQ21.71%40.89%Net Buying
View Top Biotech Stocks

Intensity Therapeutics Stock Ownership FAQ

Who owns Intensity Therapeutics?

Intensity Therapeutics (NASDAQ: INTS) is owned by 0.00% institutional shareholders, 14.63% Intensity Therapeutics insiders, and 85.37% retail investors. Lewis H. Bender is the largest individual Intensity Therapeutics shareholder, owning 2.00M shares representing 14.59% of the company. Lewis H. Bender's Intensity Therapeutics shares are currently valued at $7.80M.

If you're new to stock investing, here's how to buy Intensity Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.